Aster Capital Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
Aster Capital Management's GLUE Position: Q3 2026 in Review
Aster Capital Management opened a new position in Monte Rosa Therapeutics (GLUE) in Q3 2026: 148 shares worth $1.77K. The stake represents ﹤0.01% of the portfolio and ranks #903 among its holdings.
190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Aster Capital Management held 148 shares of Monte Rosa Therapeutics worth $1.77K as of Q3 2026.
- Monte Rosa Therapeutics was a new Aster Capital Management position in Q3 2026.
- Monte Rosa Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #903 holding.
- 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.